EUVIMEDEUVIMED entdecken
Open Access

Transferrin receptor-mediated transport at the blood-brain barrier is elevated during early development and maintained across aging and in an Alzheimer’s mouse model

Vanessa O Torres iD, Michelle E Pizzo, Darren Chan iD, Jason C Dugas, David Huynh, David Joy iD, Eric K Liang, Lily Sarrafha, Isabel Becerra, Roni Chau iD, Kylie S Chew iD, Johann Chow iD und 19 weitere

Journal of Cerebral Blood Flow & Metabolism · 2026-01 · 46 (1) · 20-35

DOI: 10.1177/0271678x251361997 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cerebral Blood Flow & Metabolism, online erschienen am 16.08.2025. Verfasst von Vanessa O Torres und 30 weiteren Autor:innen. Beteiligte Einrichtung: Denali Therapeutics, South San Francisco, CA, USA. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Receptors, Transferrin, Alzheimer Disease, Aging. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transferrin receptor (TfR)-targeting of biologics has emerged as a promising strategy to improve drug delivery across the blood-brain barrier (BBB). However, most preclinical studies evaluating TfR-enabled drugs have been conducted in young adult animals. It remains unclear whether age and aging-related diseases impact TfR protein levels and/or BBB transport capacity. Here, we utilized a previously described TfR-targeting antibody transport vehicle (ATV TfR ) to investigate how healthy aging and disease progression in the 5xFAD mouse model of Alzheimer’s disease (AD) impact TfR protein and TfR-mediated brain delivery. ATV TfR transport capacity remained stable across 3- to 24-month-old healthy mice and 5xFAD progression did not impair ATV TfR brain transport up to 10.5 months, despite significant amyloid burden. Interestingly, neonates exhibited significantly elevated levels of vascular TfR protein and ATV TfR brain exposure compared to adult mice. Furthermore, vascular TfR in AD patient brains was similar to age-matched controls, suggesting conserved TfR transport is also likely in human AD. Overall, our data demonstrates broad functional utility for TfR-based brain delivery in both healthy aging and in an AD mouse model. Additionally, elevated TfR-mediated brain delivery during early mouse development highlights the potential of added efficacy in utilizing such platforms in disease treatment of infants and children.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood-Brain BarrierReceptors, TransferrinAlzheimer DiseaseAgingAnimalsMiceDisease Models, AnimalHumansMice, TransgenicMaleFemaleBrainBiological Transport

Stichwörter der Autor:innen

Alzheimer’s diseaseantibody transport vehicleblood-brain barrierhealthy agingtransferrin receptor

Substanzen

Receptors, Transferrin

Autor:innen und Institutionen

  • Denali Therapeutics, South San Francisco, CA, USA.
  • Department of Pharmaceutics, University of Minnesota, Minneapolis, MN, USA.

ORCID-Profile: Vanessa O Torres, Darren Chan, David Joy, Roni Chau, Kylie S Chew, Johann Chow, Claire B Discenza

Zitieren

APA

Torres, V. O., Pizzo, M. E., Chan, D., Dugas, J. C., Huynh, D., Joy, D., Liang, E. K., Sarrafha, L., Becerra, I., Chau, R., Chew, K. S., Chow, J., Discenza, C. B., Earr, T. K., Furaso, L., Khoury, N., Lechtenberg, K. J., Leung, A. W., Nguyen, H. N., …, & Zuchero, Y. J. Y. (2026). Transferrin receptor-mediated transport at the blood-brain barrier is elevated during early development and maintained across aging and in an Alzheimer’s mouse model. Journal of Cerebral Blood Flow & Metabolism, 46(1), 20-35. https://doi.org/10.1177/0271678x251361997

Vancouver

Torres VO, Pizzo ME, Chan D, Dugas JC, Huynh D, Joy D, et al. Transferrin receptor-mediated transport at the blood-brain barrier is elevated during early development and maintained across aging and in an Alzheimer’s mouse model. Journal of Cerebral Blood Flow & Metabolism. 2026;46(1):20-35. doi:10.1177/0271678x251361997

BibTeX
@article{Torres2026,
  author = {Torres, Vanessa O and Pizzo, Michelle E and Chan, Darren and Dugas, Jason C and Huynh, David and Joy, David and Liang, Eric K and Sarrafha, Lily and Becerra, Isabel and Chau, Roni and Chew, Kylie S and Chow, Johann and Discenza, Claire B and Earr, Timothy K and Furaso, Laura and Khoury, Nathalie and Lechtenberg, Kendra J and Leung, Amy W and Nguyen, Hoang N and Ojo, Emmanuel S and Roche, Elysia and Simon, Matthew J and Solanoy, Hilda and Tong, Mabel and Tong, Raymond K and Henne, Kirk and Lewcock, Joseph W and Watts, Ryan J and Calvert, Meredith E and Thorne, Robert G and Zuchero, Y Joy Yu},
  title = {Transferrin receptor-mediated transport at the blood-brain barrier is elevated during early development and maintained across aging and in an Alzheimer’s mouse model},
  journal = {Journal of Cerebral Blood Flow & Metabolism},
  year = {2026},
  volume = {46},
  number = {1},
  pages = {20--35},
  doi = {10.1177/0271678x251361997}
}
Kostenlos starten →